113 related articles for article (PubMed ID: 33821713)
1. Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patients.
Sanguineti G; Pellini R; Vidiri A; Marzi S; D'Urso P; Terrenato I; Farneti A; Fuga V; Ungania S; Landoni V
Tumori; 2021 Dec; 107(6):514-524. PubMed ID: 33821713
[TBL] [Abstract][Full Text] [Related]
2. Benchmarking techniques for stereotactic body radiotherapy for early-stage glottic laryngeal cancer: LINAC-based non-coplanar VMAT vs. Cyberknife planning.
Zhang Y; Chiu T; Dubas J; Tian Z; Lee P; Gu X; Yan Y; Sher D; Timmerman R; Zhao B
Radiat Oncol; 2019 Nov; 14(1):193. PubMed ID: 31684993
[TBL] [Abstract][Full Text] [Related]
3. Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.
Ding C; Chun SG; Sumer BD; Nedzi LA; Abdulrahman RE; Yordy JS; Lee P; Hrycushko B; Solberg TD; Ahn C; Timmerman RD; Schwartz DL
Med Dosim; 2017 Summer; 42(2):90-96. PubMed ID: 28438431
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
6. Evaluating different radiotherapy treatment plans, in terms of critical organ scoring index, conformity index, tumor control probability, and normal tissue complication probability calculations in early glottic larynx carcinoma.
Inal A; Duman E; Ozkan EE
J Cancer Res Ther; 2020; 16(3):485-493. PubMed ID: 32719255
[TBL] [Abstract][Full Text] [Related]
7. Preliminary Simulation Study of Carotid Artery and Pharyngeal Constrictor Muscle Sparing-Radiotherapy in Glottic Carcinoma.
Ozdemir Y; Acibuci I; Selek U; Topkan E
Technol Cancer Res Treat; 2020; 19():1533033820956989. PubMed ID: 33034277
[TBL] [Abstract][Full Text] [Related]
8. Larynx motion considerations in partial larynx volumetric modulated arc therapy for early glottic cancer.
Bahig H; Nguyen-Tan PF; Filion É; Roberge D; Thanomsack P; de Guise J; Blais D; Doucet R; Létourneau-Guillon L; Lambert L
J Med Imaging Radiat Oncol; 2017 Oct; 61(5):666-673. PubMed ID: 28557310
[TBL] [Abstract][Full Text] [Related]
9. Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
Mao W; Rozario T; Lu W; Gu X; Yan Y; Jia X; Sumer B; Schwartz DL
J Appl Clin Med Phys; 2017 Jan; 18(1):157-163. PubMed ID: 28291932
[TBL] [Abstract][Full Text] [Related]
10. Study design and early result of a phase I study of SABR for early-stage glottic cancer.
Yu T; Wee CW; Choi N; Wu HG; Kang HC; Park JM; Kim JI; Kim JH; Kwon TK; Chung EJ
Laryngoscope; 2018 Nov; 128(11):2560-2565. PubMed ID: 29756264
[TBL] [Abstract][Full Text] [Related]
11. Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy.
Wang S; Zheng D; Lin C; Lei Y; Verma V; Smith A; Ma R; Enke CA; Zhou S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819851520. PubMed ID: 31195891
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of two treatment planning systems for spine SBRT.
Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
[TBL] [Abstract][Full Text] [Related]
13. A dosimetric comparative analysis of Brainlab elements and Eclipse RapidArc for spine SBRT treatment planning.
Deshazer G; Narayanasamy G; Bimali M; Galhardo E; Kalantari F; Xia F; Peñagarícano J; Morrill S
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35086071
[No Abstract] [Full Text] [Related]
14. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
15. Organ motion in linac-based SBRT for glottic cancer.
Perillo A; Landoni V; Farneti A; Sanguineti G
Radiat Oncol; 2021 Jun; 16(1):106. PubMed ID: 34118965
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison of two arc-based stereotactic body radiotherapy techniques for early-stage lung cancer.
Liu H; Ye J; Kim JJ; Deng J; Kaur MS; Chen ZJ
Med Dosim; 2015; 40(1):76-81. PubMed ID: 25499078
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of spine stereotactic body radiotherapy for patients with large tumors in multiple vertebrae undergoing re-irradiation: Dosimetric challenge using 3 different beam delivery techniques.
Furuya T; Phua JH; Ito K; Karasawa K
Med Dosim; 2019 Winter; 44(4):415-420. PubMed ID: 30929978
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer.
Seppälä J; Suilamo S; Tenhunen M; Sailas L; Virsunen H; Kaleva E; Keyriläinen J
Technol Cancer Res Treat; 2017 Apr; 16(2):238-245. PubMed ID: 28279147
[TBL] [Abstract][Full Text] [Related]
19. Irradiated volume and arytenoid edema after radiotherapy for T1 glottic carcinoma.
Inoue T; Inoue T; Chatani M; Teshima T
Strahlenther Onkol; 1992 Jan; 168(1):23-6. PubMed ID: 1734586
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric analysis between carbon ion radiotherapy and stereotactic body radiotherapy in stage I lung cancer.
Ebara T; Shimada H; Kawamura H; Shirai K; Saito J; Kawashima M; Tashiro M; Ohno T; Kanai T; Nakano T
Anticancer Res; 2014 Sep; 34(9):5099-104. PubMed ID: 25202098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
